Yulong Yang Selected Research

Inflammation (Inflammations)

1/2024	Identification of changes in bile composition in pancreaticobiliary reflux based on liquid chromatography/mass spectrometry metabolomics.
10/2023	Paeonol reduces microbial metabolite α-hydroxyisobutyric acid to alleviate the ROS/TXNIP/NLRP3 pathway-mediated endothelial inflammation in atherosclerosis mice.
1/2019	N-Acylethanolamine acid amidase (NAAA) inhibitor F215 as a novel therapeutic agent for osteoarthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yulong Yang Research Topics

Disease

6	Neoplasms (Cancer) 02/2024 - 02/2007
5	Atherosclerosis 03/2024 - 01/2022
4	Hepatolenticular Degeneration (Wilson's Disease) 09/2023 - 01/2022
3	Inflammation (Inflammations) 01/2024 - 01/2019
2	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 01/2023
2	Stomach Neoplasms (Stomach Cancer) 01/2019 - 01/2019
1	Hereditary Sensory and Motor Neuropathy (Dejerine Sottas Disease) 02/2024
1	Osteoporosis 02/2024
1	Parkinson Disease (Parkinson's Disease) 09/2023
1	Lung Diseases (Lung Disease) 01/2023
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Dyskinesias (Dyskinesia) 01/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Colonic Neoplasms (Colon Cancer) 01/2023
1	Deglutition Disorders (Dysphagia) 01/2023
1	Lymphatic Metastasis 01/2023
1	Dystonia (Limb Dystonia) 12/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Dysbiosis 01/2022
1	Cholestasis 08/2021
1	Gallstones (Gallstone) 08/2021
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Osteoarthritis 01/2019
1	Pain (Aches) 01/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2016
1	Hemobilia 02/2015
1	Hyperamylasemia 02/2015
1	Pancreatitis 02/2015
1	Obstructive Jaundice (Cholestatic Jaundice) 02/2015
1	Acute Cholecystitis 02/2015
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 02/2013
1	Cognitive Dysfunction 02/2013
1	Fibrosis (Cirrhosis) 03/2007
1	Prostatic Neoplasms (Prostate Cancer) 02/2007

Drug/Important Bio-Agent (IBA)

4	paeonolIBA 02/2024 - 01/2022
4	Messenger RNA (mRNA)IBA 09/2023 - 01/2019
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2021
3	Apolipoproteins E (ApoE)IBA 03/2024 - 01/2022
3	MicroRNAs (MicroRNA)IBA 02/2024 - 01/2022
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2022
2	AcidsIBA 10/2023 - 01/2019
2	Long Noncoding RNAIBA 09/2023 - 01/2019
2	Ceruloplasmin (Ferroxidase)IBA 01/2023 - 01/2022
2	Therapeutic UsesIBA 01/2019 - 02/2013
1	Antineoplastic Agents (Antineoplastics)IBA 02/2024
1	Sorafenib (BAY 43-9006)FDA Link 02/2024
1	SiliconIBA 02/2024
1	Fluorescent Dyes (Fluorescent Probes)IBA 02/2024
1	LipidsIBA 01/2024
1	Amino Acids FDA Link 01/2024
1	Drinking WaterIBA 10/2023
1	NF-kappa B (NF-kB)IBA 09/2023
1	SphingolipidsIBA 09/2023
1	Cholinergic Agents (Cholinergics)IBA 09/2023
1	DioxygenasesIBA 09/2023
1	LigandsIBA 09/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023
1	IodineIBA 01/2023
1	Carcinoembryonic AntigenIBA 01/2023
1	Protein Kinases (Protein Kinase)IBA 01/2023
1	StreptavidinIBA 01/2023
1	CopperIBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	Circular RNAIBA 01/2022
1	OsteopontinIBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	lipopolysaccharide AIBA 01/2022
1	Amylases FDA Link 08/2021
1	Alkaline PhosphataseIBA 08/2021
1	Alanine Transaminase (SGPT)IBA 08/2021
1	Lipase (Acid Lipase)FDA Link 08/2021
1	Nonesterified Fatty Acids (NEFA)IBA 08/2021
1	CholesterolIBA 08/2021
1	Triglycerides (Triacylglycerol)IBA 08/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2021
1	TransferasesIBA 08/2021
1	amidaseIBA 01/2019
1	N-acylethanolaminesIBA 01/2019
1	MK-886IBA 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	NAAA inhibitor F215IBA 01/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019
1	nilotinib FDA Link 11/2016
1	Imatinib Mesylate (Gleevec)FDA Link 11/2016
1	Dasatinib (BMS 354825)FDA Link 11/2016
1	MetalsIBA 02/2015
1	Prostate-Specific Antigen (Semenogelase)IBA 02/2007

Therapy/Procedure

4	Therapeutics 02/2024 - 11/2016
1	Immunotherapy 02/2024
1	Surgical Instruments (Clip) 01/2023
1	Fecal Microbiota Transplantation 01/2022
1	Stents 02/2015
1	Conservative Treatment 02/2015
1	Acupuncture Points (Acupuncture Point) 02/2013
1	Electroacupuncture 02/2013
1	Reoperation 03/2007
1	Prostatectomy (Retropubic Prostatectomy) 02/2007